 Light Infusion Technology LitxTM is a locoregional cancer treatment in which a systemically administered light-activated drug LS11 is activated locally by illuminating the diseased tissue using light-emitting diodes LEDs of a specific wavelength. The activated photosensitizer reacts with endogenous oxygen to yield highly reactive species of oxygen that cause destruction of cellular structures such as mitochondria, lysosomes and cell walls leading to irreversible cell damage and tissue death. 